Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 16.11
-0.35 (-2.13%)
Aug 31, 2026, 3:00 PM CST
SHA:600521 Market Cap
SHA:600521 has a market cap or net worth of 24.01 billion as of August 31, 2026. Its market cap has decreased by -33.35% in one year.
Market Cap
24.01B
Enterprise Value
30.52B
Revenue
8.98B
Ranking
n/a
PE Ratio
38.26
Stock Price
16.11
ChartMarket Cap Chart
Since March 4, 2003, SHA:600521's market cap has increased from 3.97B to 24.01B, an increase of 504.60%. That is a compound annual growth rate of 7.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 24.01B | -5.07% |
| Dec 31, 2025 | 25.29B | -2.34% |
| Dec 31, 2024 | 25.89B | 19.93% |
| Dec 29, 2023 | 21.59B | -33.42% |
| Dec 30, 2022 | 32.43B | 0.57% |
| Dec 31, 2021 | 32.25B | -34.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dizal (Jiangsu) Pharmaceutical | 27.29B |
| Shijiazhuang Yiling Pharmaceutical | 27.03B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.19B |
| Apeloa Pharmaceutical Co.,Ltd | 24.01B |
| Hubei Jumpcan Pharmaceutical | 23.09B |
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |